Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Klepp

Showing results (61-70 of 81) with videos related to

Pageof 9
Sort By:
European Urology|January 1, 1984
Unilateral retroperitoneal lymph node dissection in patients with non-seminomatous testicular tumor in clinical stage IS D Fosså, O Klepp, S Ous, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 10, 2010
Long-term follow-up after risk-adapted treatment in clinical stage 1 (CS1) nonseminomatous germ-cell testicular cancer (NSGCT) implementing adjuvant CVB chemotherapy. A SWENOTECA studyT Tandstad, G Cohn-Cedermark, O Dahl, et al.
Scandinavian Journal of Gastroenterology|October 1, 1984
Treatment with secretin and a cholecystokinin-like peptide in patients with pancreatic cancer. A pilot studyS Steffensrud, H Erichsen, P Røysland, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 18, 2007
Stereoselective biocatalytic synthesis of (S)-2-hydroxy-2-methylbutyric acid via substrate engineering by using "thio-disguised" precursors and oxynitrilase catalysisMartin H Fechter, Karl Gruber, Manuela Avi, et al.
Urology|February 1, 2003
Does prophylactic breast irradiation prevent antiandrogen-induced gynecomastia? Evaluation of 253 patients in the randomized Scandinavian trial SPCG-7/SFUO-3A Widmark, S D Fosså, P Lundmo, et al.
Scandinavian Journal of Urology and Nephrology|January 1, 1984
Multi-modality treatment in males with advanced malignant germ cell tumours. II. Experience with surgery and radiotherapy following cis-platinum-based chemotherapyS D Fosså, O Klepp, S Ous, et al.
Scandinavian Journal of Urology and Nephrology|January 1, 1984
Multi-modality treatment of advanced malignant germ cell tumours in males. I. Experience with cis-platinum-based combination chemotherapyO Klepp, S D Fosså, S Ous, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2005
Blood pressure and body mass index in long-term survivors of testicular cancerH Sagstuen, N Aass, S D Fosså, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1990
Early clinical stages (CS1, CS1Mk+ and CS2A) of non-seminomatous testis cancer. Value of pre- and post-orchiectomy serum tumor marker information in prediction of retroperitoneal lymph node metastases. Swedish-Norwegian Testicular Cancer Project (SWENOTECA)O Klepp, P Flodgren, H Maartman-Moe, et al.
Journal of Cancer Survivorship : Research and Practice|September 17, 2008
Predicted cardiovascular mortality and reported cardiovascular morbidity in testicular cancer survivorsH S Haugnes, N Aass, S D Fosså, et al.
Pageof 9

Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
European Urology|January 1, 1984
Unilateral retroperitoneal lymph node dissection in patients with non-seminomatous testicular tumor in clinical stage IS D Fosså, O Klepp, S Ous, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 10, 2010
Long-term follow-up after risk-adapted treatment in clinical stage 1 (CS1) nonseminomatous germ-cell testicular cancer (NSGCT) implementing adjuvant CVB chemotherapy. A SWENOTECA studyT Tandstad, G Cohn-Cedermark, O Dahl, et al.
Scandinavian Journal of Gastroenterology|October 1, 1984
Treatment with secretin and a cholecystokinin-like peptide in patients with pancreatic cancer. A pilot studyS Steffensrud, H Erichsen, P Røysland, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 18, 2007
Stereoselective biocatalytic synthesis of (S)-2-hydroxy-2-methylbutyric acid via substrate engineering by using "thio-disguised" precursors and oxynitrilase catalysisMartin H Fechter, Karl Gruber, Manuela Avi, et al.
Urology|February 1, 2003
Does prophylactic breast irradiation prevent antiandrogen-induced gynecomastia? Evaluation of 253 patients in the randomized Scandinavian trial SPCG-7/SFUO-3A Widmark, S D Fosså, P Lundmo, et al.
Scandinavian Journal of Urology and Nephrology|January 1, 1984
Multi-modality treatment in males with advanced malignant germ cell tumours. II. Experience with surgery and radiotherapy following cis-platinum-based chemotherapyS D Fosså, O Klepp, S Ous, et al.
Scandinavian Journal of Urology and Nephrology|January 1, 1984
Multi-modality treatment of advanced malignant germ cell tumours in males. I. Experience with cis-platinum-based combination chemotherapyO Klepp, S D Fosså, S Ous, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2005
Blood pressure and body mass index in long-term survivors of testicular cancerH Sagstuen, N Aass, S D Fosså, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1990
Early clinical stages (CS1, CS1Mk+ and CS2A) of non-seminomatous testis cancer. Value of pre- and post-orchiectomy serum tumor marker information in prediction of retroperitoneal lymph node metastases. Swedish-Norwegian Testicular Cancer Project (SWENOTECA)O Klepp, P Flodgren, H Maartman-Moe, et al.
Journal of Cancer Survivorship : Research and Practice|September 17, 2008
Predicted cardiovascular mortality and reported cardiovascular morbidity in testicular cancer survivorsH S Haugnes, N Aass, S D Fosså, et al.
Pageof 9